Aprameya Engineering
add_icon

Aprameya Engineering

151.00
-1.75
(-1.15%)
Market Cap
287.50 Cr
PE Ratio
56.78
Volume
10,000.00
Day High - Low
152.00 - 149.00
52W High-Low
360.00 - 140.25
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
287.50 Cr
EPS
2.65
PE Ratio
56.78
PB Ratio
4.19
Book Value
36.45
EBITDA
10.42
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
25.08
Debt to Equity
0.83
Forecast For
Actual

Company News

View All News
Caret
positive
Aprameya Engineering's subsidiary Aprameya Medtech signed an exclusive sales and marketing agreement with Sonoscape Medical India for advanced surgical imaging systems in Southern and Western India.
neutral
Aprameya Engineering's Board approved audited standalone and consolidated financial results for the half year and year ended March 31, 2026, with standalone revenue from operations at Rs. 5,474.75 Lakhs.
positive
Aprameya Engineering achieved a net profit of 68 million rupees in H1, marking a significant turnaround from a loss of 18 million rupees in the same period last year. The company's revenue surged to 421 million rupees compared to 93 million rupees in the previous year's H1 period, representing substantial year-over-year growth across both profitability and revenue metrics.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,650.20
#1 16,726.34
52.18
#1 1,875.26
6.61
#1 326
-29.19
63.89
259.03
1,378.20
96.13
422.51
3.45
16
-58.82
63.05
546.50
1,274.89
24.12
341.74
5.93
56
#1 750.00
59.96
224.76
1,235.33
42.64
271.50
12.00
22
134.88
52.45
465.80
824.21
27.46
292.67
56.84
30
-
44.81
156.92
697.52
#1 18.34
410.77
22.29
36
46.36
54.78
373.35
647.27
64.71
278.87
10.97
10
-68.29
39.83
371.00
539.39
29.82
231.81
#1 107.34
19
-
49.07
378.55
454.36
22.47
71.81
7.02
21
13.73
43.44
151.00
#10 287.50
#8 56.78
#10 54.75
#10 -59.83
#10 5
-
35.73

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
-59.83 %
Net Income Growth
-71.37 %
Cash Flow Change
-6.72 %
ROE
68.10 %
ROCE
88.77 %
EBITDA Margin (Avg.)
2.84 %

Yearly Financial Results

Annual Financials
2020
2021
2022
2023
2024
2025
2026
TTM
Revenue
12
26
35
78
66
136
55
0
Expenses
11
24
25
69
59
111
44
0
EBITDA
2
3
10
10
7
25
10
0
Operating Profit %
13 %
9 %
29 %
12 %
10 %
18 %
19 %
0 %
Depreciation
0
0
0
0
0
0
0
0
Interest
1
1
0
2
2
3
4
0
Profit Before Tax
1
2
10
8
5
22
7
0
Tax
0
1
3
2
1
6
3
0
Net Profit
1
1
8
5
4
16
5
0
EPS in ₹
0.47
0.61
10.65
3.84
2.49
9.27
2.65
0.00

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
2026
Total Assets
14
11
49
62
76
144
82
Fixed Assets
1
1
2
2
1
1
1
Current Assets
12
9
43
56
70
137
73
Capital Work in Progress
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
3
Other Assets
13
10
47
60
74
143
0
Total Equity & Liabilities
14
11
49
62
76
144
82
Current Liabilities
10
6
21
30
40
73
10
Non Current Liabilities
0
1
14
12
13
6
2
Total Equity
4
4
15
20
23
64
69
Reserve & Surplus
0
0
8
6
9
45
50
Share Capital
4
4
7
14
14
19
19

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
2025
Net Cash Flow
0
-0
3
-2
0
-0
Investing Activities
-1
0
-0
-2
-1
-0
Operating Activities
0
4
10
-14
-10
-11
Financing Activities
1
-4
-8
13
11
11

Share Holding

% Holding
Sept 2022
Jul 2024
Sept 2024
Mar 2025
Sept 2025
Mar 2026
Promoter
100.00 %
73.53 %
73.53 %
73.53 %
73.53 %
74.05 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.29 %
0.00 %
0.00 %
0.00 %
0.70 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
12.11 %
15.64 %
20.81 %
21.73 %
21.07 %
Others
0.00 %
14.07 %
10.83 %
5.66 %
4.74 %
4.17 %
No of Share Holders
7
1,206
749
628
822
933

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
11 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Nov 2024 73.75 71.00
08 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 May 2025 109.00 129.30
10 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 Nov 2025 274.00 274.00
28 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 May 2026 207.55 173.00

Technical Indicators

RSI(14)
Neutral
36.75
ATR(14)
Less Volatile
8.66
STOCH(9,6)
Neutral
31.43
STOCH RSI(14)
Oversold
9.62
MACD(12,26)
Bullish
1.30
ADX(14)
Strong Trend
34.44
UO(9)
Bearish
39.50
ROC(12)
Downtrend And Accelerating
-3.96
WillR(14)
Neutral
-72.62